Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A massively parallel reporter assay of <i>MECP2</i> cis-regulatory elements reveals genetic candidates for male-biased autism.

bioRxiv : the preprint server for biology·2026
Same author

<i>Sod1</i> trisomy causes ENS developmental defects and susceptibility to Hirschsprung disease via neuronal <i>Ret</i> suppression and glial remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Using the linear references from the pangenome to discover missing autism variants.

Nature communications·2026
Same author

Joint disruption of <i>Ret</i> and <i>Ednrb</i> transcription shifts cell fate trajectories in the enteric nervous system in Hirschsprung disease.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Increasing <i>SOX10</i> Expression Overcomes Schizophrenia-Associated Early Oligodendrocyte Growth Deficits In Vitro.

Biological psychiatry global open science·2025
Same author

Sex differences in the developing human cortex intersect with genetic risk of neurodevelopmental disorders.

bioRxiv : the preprint server for biology·2025
Same journal

Diagnosis and treatment of luteal phase deficiency: a Committee Opinion.

Fertility and sterility·2026
Same journal

Confronting complexities of uterus transplantation: Balancing Innovation, Risk and Access.

Fertility and sterility·2026
Same journal

Fertility Benefits and Parental Leave Policies across Accreditation Council for Graduate Medical Education (ACGME) Programs with Ob/Gyn Residency Programs.

Fertility and sterility·2026
Same journal

Optimizing the therapeutic donor insemination cycle.

Fertility and sterility·2026
Same journal

Hormonal and metabolic effects of the administration of oral low-dose 17-β-estradiol (0.2 mg) in patients with Functional Hypothalamic Amenorrhea (FHA): A Retrospective Pilot Study.

Fertility and sterility·2026
Same journal

Biomarker or Bystander? Considering Triglyceride Glucose-Body Mass Index (TyG-BMI) in Patients with Polyendocrine Metabolic Ovarian Syndrome.

Fertility and sterility·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Safety issues in cell-based intervention trials.

Liza Dawson1, Alison S Bateman-House, Dawn Mueller Agnew

  • 1Phoebe R Berman Bioethics Institute, Johns Hopkins University, Baltimore, Maryland 21205, USA. rfaden@jhsph.edu

Fertility and Sterility
|November 11, 2003
PubMed
Summary
This summary is machine-generated.

Ethical and policy challenges in stem cell research, including human embryo use and limited animal safety data, require careful consideration for clinical translation. A national advisory committee is recommended for overseeing cell therapies.

Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

More Related Videos

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

Related Experiment Videos

Last Updated: Jun 25, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

Area of Science:

  • Biomedical Ethics
  • Stem Cell Biology
  • Health Policy

Background:

  • Stem cell research presents unique ethical and policy challenges during the transition from laboratory findings to clinical applications.
  • Existing regulatory frameworks may not fully address the complexities of cell-based therapies.

Purpose of the Study:

  • To identify and discuss novel ethical and policy challenges in stem cell research.
  • To explore safety concerns in translating stem cell-based therapies to clinical use.

Main Methods:

  • Deliberations of an interdisciplinary expert group (science, law, philosophy).
  • Analysis of ethical and policy implications of stem cell therapy development.

Main Results:

  • Three unique challenges identified: human embryo use, limited animal safety data for human stem cells, and difficulties in preclinical/clinical testing of complex cell therapies.
  • Need for standardized assays and appropriate patient selection for early trials.

Conclusions:

  • Responsible discussion among scientists, policymakers, and the public is crucial.
  • Establishment of a national advisory committee to oversee human trials of cell therapies is recommended.